REPL (STOCKS)
Replimune Group, Inc.
$15.170000
-0.070000 (-0.46%)
Prev close: $15.240000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Sushil Patel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,634.83M
- Employees
- 479
- P/E (TTM)
- -4.33
- P/B (TTM)
- 7.59
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $5.43M |
| Operating Expenses | $319.92M |
| Selling, General, and Administrative Expenses | $98.74M |
| Research and Development | $221.18M |
| Operating Income/Loss | -$319.92M |
| Income/Loss From Continuing Operations After Tax | -$314.49M |
| Income/Loss From Continuing Operations Before Tax | -$314.49M |
| Income Tax Expense/Benefit | -$551.00K |
| Net Income/Loss | -$313.94M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$313.94M |
| Net Income/Loss Available To Common Stockholders, Basic | -$313.94M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.38 |
| Diluted Earnings Per Share | -$3.38 |
| Basic Average Shares | 92,803,711 |
| Diluted Average Shares | 92,803,711 |
| Assets | $332.39M |
| Current Assets | $279.12M |
| Noncurrent Assets | $53.27M |
| Fixed Assets | $12.97M |
| Other Non-current Assets | $40.30M |
| Liabilities | $166.23M |
| Current Liabilities | $58.23M |
| Accounts Payable | $6.67M |
| Other Current Liabilities | $51.56M |
| Noncurrent Liabilities | $108.00M |
| Equity | $166.16M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $166.16M |
| Liabilities And Equity | $332.39M |
| Net Cash Flow From Operating Activities | -$280.34M |
| Net Cash Flow From Operating Activities, Continuing | -$280.34M |
| Net Cash Flow From Investing Activities | $310.84M |
| Net Cash Flow From Investing Activities, Continuing | $310.84M |
| Net Cash Flow From Financing Activities | $66.29M |
| Net Cash Flow From Financing Activities, Continuing | $66.29M |
| Exchange Gains/Losses | $1.11M |
| Net Cash Flow | $97.91M |
| Net Cash Flow, Continuing | $96.79M |
| Comprehensive Income/Loss | -$313.99M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$313.99M |
| Other Comprehensive Income/Loss | -$45.00K |